![Paul B. Little](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul B. Little
Director Ejecutivo en Insusense ApS .
Perfil
Paul B.
Little's current job(s) include being the Chief Executive Officer at Insusense ApS since 2018 and an Associate at Lundbeckfonden Emerge since 2015.
His former job(s) include being the Director-CMC & Preclinical Development at Orphazyme A and a Principal at 7TM A from 2008 to 2011.
He holds a doctorate degree from the University of Cardiff.
Cargos activos de Paul B. Little
Empresas | Cargo | Inicio |
---|---|---|
Lundbeckfonden Emerge
![]() Lundbeckfonden Emerge Investment ManagersFinance Lundbeckfonden Emerge (Emerge) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2012 and is headquartered in Copenhagen, Denmark. | Analista de Capital Privado | 01/09/2015 |
Insusense ApS
![]() Insusense ApS BiotechnologyHealth Technology Insusense ApS provides research and development in biotechnology. It conducts research and development on new medicines for treatment of diabetes, diabetes related diseases, and obesity. The company was founded by Anders Nykjær on April 19, 2010 and is headquartered in Copenhagen, Denmark. | Director Ejecutivo | 01/10/2018 |
Antiguos cargos conocidos de Paul B. Little.
Empresas | Cargo | Fin |
---|---|---|
7TM A/S
![]() 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Corporate Officer/Principal | 01/01/2011 |
ORPHAZYME A/S | Corporate Officer/Principal | - |
Formación de Paul B. Little.
University of Cardiff | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ORPHAZYME A/S | Health Technology |
Empresas privadas | 3 |
---|---|
7TM A/S
![]() 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Health Technology |
Lundbeckfonden Emerge
![]() Lundbeckfonden Emerge Investment ManagersFinance Lundbeckfonden Emerge (Emerge) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2012 and is headquartered in Copenhagen, Denmark. | Finance |
Insusense ApS
![]() Insusense ApS BiotechnologyHealth Technology Insusense ApS provides research and development in biotechnology. It conducts research and development on new medicines for treatment of diabetes, diabetes related diseases, and obesity. The company was founded by Anders Nykjær on April 19, 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Paul B. Little